Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology

Sacubitril/valsartan (SV) has been demonstrated to reduce cardiovascular mortality, hospitalization for heart failure and to induce reverse ventricular remodeling. The present study was designed to confirm the effects of SV in a selected population of patients with HFrEF and to evaluate the differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Cemin, Roberto, Casablanca, Simona, Foco, Luisa, Schoepf, Elisabeth, Erlicher, Andrea, Di Gaetano, Renato, Ermacora, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864277/
https://www.ncbi.nlm.nih.gov/pubmed/36675549
http://dx.doi.org/10.3390/jcm12020621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864277/
https://www.ncbi.nlm.nih.gov/pubmed/36675549
http://dx.doi.org/10.3390/jcm12020621

Ejemplares similares